F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on review of facility policy and clinical records, as well as staff interviews, it was determined that the
facility failed to ensure that physician's orders regarding medication administration were followed for one of
eight residents reviewed (Resident 6).
Residents Affected - Some
Findings include:
The facility policy for medication administration, dated January 15, 2025, indicated that medications are
administered in accordance with prescriber orders, and that the following information is checked/verified for
each resident prior to administering medications: allergies to medications; and vital signs, if necessary.
A quarterly Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and
care needs) for Resident 6, dated February 28, 2025, revealed that the resident was cognitively intact,
independent with personal care needs, and had diagnoses that included diabetes.
Physician's orders for Resident 6, dated February 28, 2025, included an order for the resident to receive
one-half tablet of 25 milligrams (mg) of Metoprolol Tartrate (used to treat high blood pressure) twice a day
for hypertension (high blood pressure) and to hold the medication if the resident's heart rate is less than 60.
Physician's orders, dated March 31, 2025, included an order for the resident to receive six units of Insulin
Aspart (rapid acting insulin used to lower blood sugar) three times a day and to hold the medication if the
resident's blood glucose (sugar) level was less that 120 milligrams (mg) per deciliter (dL).
Review of the Medication Administration Record (MAR) for Resident 6, dated April 2025 and May 2025,
revealed that there was no documented evidence that the resident's heart rate was checked twice each day
prior to the administration of Metoprolol Tartrate as ordered from April 1, 2025, through May 14, 2025.
Review of the MAR also revealed that six units of Insulin Aspart was administered on April 13 at 9:00 a.m.
when the resident's blood sugar level was 75 mg/dl, six units of Insulin Aspart was administered on April 17
at 9:00 a.m. when the resident's blood sugar level was 112 mg/dl, six units of Insulin Aspart was
administered on May 2 at 9:00 a.m. when the resident's blood sugar level was 98 mg/dl, six units of Insulin
Aspart was administered on May 5 at 9:00 a.m. when the resident's blood sugar level was 102 mg/dl, and
six units of Insulin Aspart was administered on May 6 at 9:00 a.m. when the resident;s blood sugar level
was 104 mg/dl.
Interview with the Assistant Director of Nursing on May 14, 2025, at 3:56 p.m. confirmed that the heart rate
for Resident 6 should have been assessed prior to the administration of Metoprolol Tartrate; however, it was
not.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395500
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395500
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Twin Lakes Rehabilitation and Healthcare Center
227 Sand Hill Road
Greensburg, PA 15601
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Interview with the Assistant Director of Nursing on May 14, 2025, at 4:05 p.m. confirmed that Insulin Aspart
was administered to Resident 6 on the above-mentioned dates and times when it should have been held
per physician's orders.
28 Pa. Code 211.12(d)(1)(5) Nursing Services.
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395500
If continuation sheet
Page 2 of 2